These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 11319673

  • 1. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients.
    Kumpusalo E, Lappi J, Miettinen H, Takala J.
    J Hum Hypertens; 2001 Apr; 15(4):255-8. PubMed ID: 11319673
    [Abstract] [Full Text] [Related]

  • 2. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M, Valerio C, Magrini F, Zanchetti A.
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [Abstract] [Full Text] [Related]

  • 3. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Sep; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 4. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y, Damle A.
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population.
    Barrios V, Escobar C, Calderon A, Ribas L, Marti D, Asin E.
    Blood Press; 2008 May; 17(2):110-5. PubMed ID: 18568700
    [Abstract] [Full Text] [Related]

  • 7. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
    Niiranen TJ, Jula AM, Kantola IM, Karanko H, Reunanen A.
    J Hum Hypertens; 2007 Oct; 21(10):788-94. PubMed ID: 17637793
    [Abstract] [Full Text] [Related]

  • 8. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
    Lozano JV, Redón J, Cea-Calvo L, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J.
    Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
    [Abstract] [Full Text] [Related]

  • 9. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of left ventricular hypertrophy as assessed by electrocardiogram in treated hypertensive persons in general practice.
    van den Hoogen JP, van Kruijsdijk MC, van Ree JW, Mokkink HG, Thien T, van Weel C.
    J Hum Hypertens; 1993 Oct; 7(5):473-7. PubMed ID: 8263888
    [Abstract] [Full Text] [Related]

  • 11. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 12. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct 12; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 13. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May 12; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 14. Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study.
    Shibamiya T, Obara T, Ohkubo T, Shinki T, Ishikura K, Yoshida M, Satoh M, Hashimoto T, Hara A, Metoki H, Inoue R, Asayama K, Kikuya M, Imai Y, J-HOME-Elderly study group.
    Hypertens Res; 2010 Jul 12; 33(7):670-7. PubMed ID: 20431591
    [Abstract] [Full Text] [Related]

  • 15. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May 12; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 16. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 17. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B, Güneri S, Badak O, Aslan O, Tamci B.
    Anadolu Kardiyol Derg; 2002 Jun 28; 2(2):121-9; AXVII. PubMed ID: 12134537
    [Abstract] [Full Text] [Related]

  • 18. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion.
    Stenehjem AE, Bjørnerheim R, Os I.
    Blood Press; 2007 Jun 28; 16(2):87-94. PubMed ID: 17612906
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E, Palermo A, Mulè G, Cusimano P, Cerasola G, Rini GB.
    Eur J Prev Cardiol; 2013 Oct 28; 20(5):854-61. PubMed ID: 22556375
    [Abstract] [Full Text] [Related]

  • 20. Treatment situation of hypertensive patients in Finnish primary health care.
    Kumpusalo E, Pärnänen H, Takala J.
    Blood Press Suppl; 1997 Oct 28; 1():35-9. PubMed ID: 9285106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.